Prime Minister Opens e-Therapeutics’ Drug Discovery Centre near Oxford

News Feb 27, 2012

e-Therapeutics has announced that the UK’s Prime Minister, the Right Honourable David Cameron, MP, has opened the Company’s new drug discovery centre at Long Hanborough near Oxford.

The centre, which is located in the Prime Minister’s parliamentary constituency, will spearhead e-Therapeutics’ pioneering work in network pharmacology, a distinctive approach to the discovery of medicines with potential to produce new and improved treatments for complex diseases such as cancer.

The Prime Minister said: “e-Therapeutics is a fascinating and innovative business in my constituency. Their use of pioneering science has the potential to deliver great results and I very much hope that their treatments are successful.”

Professor Malcolm Young, founder and CEO of e-Therapeutics, said: “We are delighted to have the Prime Minister open our new drug discovery centre near Oxford, which is a world centre of excellence in the science that underpins our business.”

Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until Now

News

A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.

Researchers Reveal How Superbug Secretes It’s Toxin

News

Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.

Key Psychiatric Drug Target Comes Into Focus

News

Researchers have determined the crystal structure of a specific dopamine receptor called D4 at an incredibly high resolution which is a major step towards designing improved psychiatric drugs with fewer side effects.